Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy for prostate cancer

Lauren Turner, Karen Poole, Sara Faithfull, Bruce A. Griffin

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Androgen deprivation therapy (ADT) is used widely as part of a combined modality for the treatment of prostate cancer. However, ADT has also been associated with the development of cardiometabolic complications that can increase mortality from cardiovascular events. There is emerging evidence to suggest that ADT-related cardiometabolic risk can be mitigated by diet and lifestyle modification. While the clinical focus for a nutritional approach for achieving this effect is unclear, it may depend upon the timely assessment and targeting of dietary changes to the specific risk phenotype of the patient. The present review aims to address the metabolic origins of ADT-related cardiometabolic risk, existing evidence for the effects of dietary intervention in modifying this risk, and the priorities for future dietary strategies.

Original languageEnglish
Pages (from-to)220-232
Number of pages13
JournalNutrition Research Reviews
Volume30
Issue number2
DOIs
StatePublished - Dec 1 2017

Keywords

  • Androgen deprivation therapy
  • Cardiometabolic risk
  • Metabolic syndrome
  • Nutritional management
  • Prostate cancer

Fingerprint

Dive into the research topics of 'Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy for prostate cancer'. Together they form a unique fingerprint.

Cite this